These data suggest that the ACM promotes upregulation of the scavenger receptor CD36 in the tumor cells, thereby leading to activation of the nuclear receptor PPARγ, which, in turn, results in the transcriptional induction of CD36 and FABP4 genes [27,28]. The gene discussed is CD36; the disease is neoplasm.